5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | BUY | BUY | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 7.67▼ | 7.65▲ | 7.63▲ | 7.43▲ | 7.17▲ |
MA10 | 7.67▼ | 7.61▲ | 7.57▲ | 7.14▲ | 8.05▼ |
MA20 | 7.66▼ | 7.56▲ | 7.48▲ | 7.11▲ | 8.78▼ |
MA50 | 7.63▲ | 7.44▲ | 7.25▲ | 8.20▼ | 9.86▼ |
MA100 | 7.56▲ | 7.20▲ | 6.96▲ | 8.91▼ | 10.98▼ |
MA200 | 7.49▲ | 6.92▲ | 7.52▲ | 9.88▼ | 10.81▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.002▼ | 0.007▲ | 0.005▲ | 0.164▲ | -0.152▼ |
RSI | 52.540▲ | 70.505▲ | 70.795▲ | 53.599▲ | 38.334▼ |
STOCH | 58.889 | 92.370▲ | 85.286▲ | 94.068▲ | 18.661▼ |
WILL %R | -80.000▼ | -12.121▲ | -10.811▲ | -1.689▲ | -61.053 |
CCI | 66.500 | 95.150 | 136.451▲ | 137.458▲ | -67.388 |
Wednesday, April 30, 2025 11:13 AM
PRINCETON, N.J., April 21, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a conference call and live audio webcast on Thursday, May 1 ...
|
Wednesday, April 30, 2025 09:01 AM
Analysts are estimating that Amicus Therapeutics will report an earnings per share (EPS) of $0.08. The announcement from Amicus Therapeutics is eagerly anticipated, with investors seeking news of ...
|
Wednesday, April 30, 2025 12:16 AM
Clearwater Paper Corp (CLW) reports robust sales growth and strategic investments, despite facing input cost inflation and market headwinds.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
30/04/25 | 7.49 | 7.705 | 7.37 | 7.68 | 4,493,694 |
29/04/25 | 7.36 | 7.58 | 7.325 | 7.51 | 3,182,664 |
28/04/25 | 7.35 | 7.41 | 7.26 | 7.39 | 4,267,093 |
25/04/25 | 7.14 | 7.38 | 7.05 | 7.35 | 3,683,901 |
24/04/25 | 7.14 | 7.21 | 7.01 | 7.20 | 4,644,682 |
23/04/25 | 7.00 | 7.25 | 6.9709 | 7.10 | 5,787,624 |
22/04/25 | 6.79 | 6.92 | 6.72 | 6.91 | 3,907,883 |
21/04/25 | 6.78 | 6.915 | 6.66 | 6.71 | 2,750,349 |
17/04/25 | 6.64 | 6.88 | 6.63 | 6.83 | 3,105,765 |
16/04/25 | 6.85 | 6.92 | 6.65 | 6.70 | 3,313,665 |
|
|
||||
|
|
||||
|
|